AGNC Investment Corp (AGNC) Stock Price Today
Key Stats
- $11.40BMarket Cap
- 35,023,675Volume
- Real EstateSector
- $12.1752W High
- $9.6252W Low
- 102 DaysTypical Hold Time
- $100.39BEnterprise Value
- 14.97%Div Yield
- 26% Sell | 74% BuyTrading Activity
Track AGNC Investment Corp (AGNC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AGNC Investment Corp has traded between a low of $9.45 and a high of $12.17, highlighting its annual price range. Buy and sell AGNC Investment Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About AGNC Investment Corp
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.
Most Recent News
Several high-volume stocks plunge sharply amid profit-taking despite positive updates.
Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.
Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.
Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.